Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Regulatory Science

Background:

• Adaptive clinical trial designs offer flexibility but require careful oversight.
• Data Safety Monitoring Boards (DSMBs) are crucial for ensuring patient safety and trial integrity.
• Interactions between researchers and DSMBs can be complex, especially with novel trial designs.

Purpose of the Study:

• To illustrate common challenges and best practices in DSMB interactions.
• To provide insights from real-world experiences with adaptive trial oversight.
• To enhance understanding of DSMB roles in adaptive clinical trials.

Main Methods:

• The article presents a series of vignettes based on the author's personal experiences.
• These vignettes focus on interactions during the design and ongoing monitoring phases of clinical trials.
• The trials discussed specifically employed adaptive designs.

Main Results:

• Vignettes highlight the importance of clear communication and data transparency with DSMBs.
• Experiences demonstrate the need for proactive engagement with DSMBs throughout the trial lifecycle.
• The author's reflections underscore the value of DSMBs in navigating adaptive design complexities.

Conclusions:

• Effective collaboration with DSMBs is essential for successful adaptive clinical trials.
• Sharing experiences can improve future DSMB interactions and trial conduct.
• DSMBs play a vital role in the ethical and scientific rigor of adaptive study designs.